The Western Cape has released South Africa’s first local data, which finds that although people with these common illnesses are more vulnerable to COVID-19, they are less likely to die from the new coronavirus than many previously thought.
Background: Chronic respiratory illnesses and respiratory infections are common in HIV-positive populations. It seems reasonable that HIV-positive people experience more respiratory symptoms, such as coughing and breathlessness, than those who are HIV-negative.
Men living with HIV (MLHIV) have a high burden of human papillomavirus (HPV)-related cancer. Understanding serological dynamics of HPV in men can guide decisions on introducing HPV vaccination and monitoring impact.
With the rapid spread of COVID-19 across Africa, m2m President & CEO, Frank Beadle de Palomo, looks at how countries and organisations are harnessing lessons learned from the HIV/AIDS response to mitigate the impact of this new pandemic.
The HIV pandemic provides lessons for the response to the novel coronavirus disease 2019 (COVID-19) pandemic: no vaccine is available for either and there are no licensed pharmaceuticals for COVID-19, just as there was not for HIV infection in the early years.